This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Learn ways to build wealth even if you don't have a high income. Start your wealth-building journey today with practical strategies!
26,798 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
The U.S. government has halted Anthropic's Fable 5 and Mythos 5, citing a security vulnerability. The move shakes fin...
Investors awakened to a rough start for cruise stocks as Norwegian Cruise Line Holdings shares slid. This piece break...
Warby Parker lit up the market with a notable stock move this week. This article breaks down the drivers behind the s...
As AI reshapes the job market, a leading tech founder argues Gen Z should pursue two college majors to stay competiti...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
Paysign faced a sharp intraday drop after its latest earnings report, even as revenue and earnings beat expectations....
Micron stock just dropped as traders weigh demand for memory parts against a backdrop of cyclical pricing. This artic...
Palantir surged on AI optimism, then cooled. This guide breaks down March catalysts, valuation, and practical ways to...
As Nvidia prepares to report, investors watch for more than headline numbers. This article explains Nvidia's billion ...
Pagaya Technologies just saw a notable insider move when its CEO purchased shares. This article examines what that co...
BlackSky faces a pivotal year as government programs, commercial demand, and deployment costs shape its 2026 earnings...